Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer

This publication has 26 references indexed in Scilit:

• The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer
  Clinical Cancer Research, 2005
• Biomarker Changes During Neoadjuvant Anastrozole, Tamoxifen, or the Combination: Influence of Hormonal Status and HER-2 in Breast Cancer—A Study from the IMPACT Trialists
  Journal of Clinical Oncology, 2005
• Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma
  International Journal of Gynecologic Cancer, 2004
• HER-2 Expression and Cell Proliferation: Prognostic Markers in Patients With Node-Negative Breast Cancer
  Journal of Clinical Oncology, 2003
• International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma
  JNCI Journal of the National Cancer Institute, 2003
• Serum Vascular Endothelial Growth Factor in Epithelial Ovarian Neoplasms: Correlation with Patient Survival
  Gynecologic Oncology, 1999
• Vascular endothelial growth factor expression in early stage ovarian carcinoma
  Cancer, 1997
• Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor Activity
  Japanese Journal of Cancer Research, 1996
• Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
  Journal of Molecular Medicine, 1995
• Angiogenesis in cancer, vascular, rheumatoid and other disease
  Nature Medicine, 1995